In/FW
vivo/FW
function/NN
of/IN
an/DT
interleukin/NN
2/CD
receptor/NN
beta/NN
chain/NN
(/(
IL-2Rbeta/NN
)/)
//:
IL-4Ralpha/NN
cytokine/NN
receptor/NN
chimera/NN
potentiates/VBZ
allergic/JJ
airway/NN
disease/NN
./.

Strength/NN
of/IN
T/NN
cell/NN
receptor/NN
(/(
TCR/NN
)/)
signaling/NN
,/,
coreceptors/NNS
,/,
costimulation/NN
,/,
antigen-presenting/JJ
cell/NN
type/NN
,/,
and/CC
cytokines/NNS
all/DT
play/VBP
crucial/JJ
roles/NNS
in/IN
determining/VBG
the/DT
efficiency/NN
with/IN
which/WDT
type/NN
2/CD
T/NN
lymphocytes/NNS
(/(
Th2/NN
,/,
Tc2/NN
)/)
develop/VBP
from/IN
uncommitted/JJ
precursors/NNS
./.
=====
To/TO
investigate/VB
in/FW
vivo/FW
regulatory/JJ
mechanisms/NNS
that/WDT
control/VBP
the/DT
population/NN
of/IN
type/NN
2/CD
T/NN
cells/NNS
and/CC
disease/NN
susceptibility/NN
,/,
we/PRP
have/VBP
created/VBN
lines/NNS
of/IN
transgenic/JJ
mice/NNS
in/IN
which/WDT
expression/NN
of/IN
a/DT
chimeric/JJ
cytokine/NN
receptor/NN
(/(
the/DT
mouse/NN
interleukin/NN
2/CD
receptor/NN
beta/NN
chain/NN
[/(
IL-2Rbeta/NN
]/)
extracellular/JJ
domain/NN
fused/VBN
to/TO
the/DT
cytoplasmic/JJ
tail/NN
of/IN
IL-4Ralpha/NN
)/)
is/VBZ
targeted/VBN
to/TO
the/DT
T/NN
lymphoid/JJ
lineage/NN
using/VBG
the/DT
proximal/JJ
lck/NN
promoter/NN
./.
=====
This/DT
chimera/NN
transduced/VBD
IL-4-specific/JJ
signals/NNS
in/IN
response/NN
to/TO
IL-2/NN
binding/NN
and/CC
dramatically/RB
enhanced/VBD
type/NN
2/CD
responses/NNS
(/(
IL-4/NN
,/,
IL-5/NN
,/,
and/CC
immunoglobulin/NN
E/NN
production/NN
)/)
upon/IN
in/FW
vitro/FW
TCR/NN
stimulation/NN
or/CC
in/FW
vivo/FW
antigen/NN
challenge/NN
./.
=====
Thus/RB
,/,
type/NN
2/CD
effector/NN
function/NN
was/VBD
augmented/VBN
by/IN
IL-4/NN
signals/NNS
transduced/VBN
through/IN
a/DT
chimeric/JJ
receptor/NN
expressed/VBN
in/IN
a/DT
T/NN
cell-specific/JJ
manner/NN
./.
=====
This/DT
influence/NN
was/VBD
sufficient/JJ
for/IN
establishment/NN
of/IN
antigen-induced/JJ
allergic/JJ
airway/NN
hyperresponsiveness/NN
on/IN
a/DT
disease-resistant/JJ
background/NN